Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Relafen
Synonyms :
Class :
NSAIDs
Dosage forms & Strengths:Â
Adult:Â
Tablet:Â
500 mgÂ
750 mgÂ
1000
mg
Tablet
Orally 
once a day
In case of renal impairment, 500 mg orally once daily:
1000
mg
Tablet
Orally 
once a day
Safety and efficacy are not seen in pediatricsÂ
NSAIDs may enhance the anticoagulant effect of Heparin
NSAIDs may enhance the anticoagulant effect of Heparin
interaction with NSAIDs may lead to increased toxicity such as myelosuppression, renal toxicity, and GI toxicity
interaction with NSAIDs may lead to increased toxicity such as myelosuppression, renal toxicity, and GI toxicity
ACE Inhibitors may enhance the adverse/toxic effect of NSAIDs
ACE Inhibitors may enhance the adverse/toxic effect of NSAIDs
ACE Inhibitors may enhance the adverse/toxic effect of NSAIDs
ACE Inhibitors may enhance the adverse/toxic effect of NSAIDs
ACE Inhibitors may enhance the adverse/toxic effect of NSAIDs
it may diminish the excretion rate when combined with gadofosveset, resulting in an enhanced serum level
When nabumetone is used together with bufexamac, this leads to enhanced risk or seriousness of adverse outcomes
nabumetone leads to a reduction in the rate of excretion of nitric oxide, which leads to an increased level of serum
When aceclofenac is used together with nifenazone, this leads to enhanced risk or seriousness of adverse events
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents
when combined may increase anticoagulation
when combined may increase anticoagulation
When nabumetone is aided by hesperetin, it reduces hesperetin’s metabolism
when both drugs are combined, there may be an increased effect of nabumetone by acidic drug competition for renal tubular clearance 
>10%:Â
Diarrhea Â
Dyspepsia Â
Abdominal painÂ
1-10%:Â
Constipation Â
Dizziness Â
Edema Â
Flatulence Â
Headache Â
Nausea Â
Positive stool guaiac Â
Pruritus Â
Rash Â
Tinnitus Â
Dry mouth Â
Fatigue Â
Gastritis Â
Increased sweating Â
Insomnia Â
Nervousness Â
Somnolence Â
Stomatitis Â
VomitingÂ
Nabumetone is contraindicated in patients hypersensitive to the formulation’s active ingredient and other excipients.Â
Pregnancy consideration:Â Â
Category CÂ
Breastfeeding warnings:Â Â
Not indicated for lactating women.Â
Pregnancy category:Â
Patient information leafletÂ
Generic Name: nabumetoneÂ
Pronounced: na-byoo-me-toneÂ
Why do we use nabumetone?Â
Nabumetone belongs to the category of NSAIDs. It treats osteoarthritis and rheumatoid arthritis.Â